1 – 27 of 27
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Needs of amyloidosis patients and their care providers : design & first results of the AMY-NEEDS research and care program
(
- Contribution to journal › Article
-
Mark
Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study
(
- Contribution to journal › Article
- 2023
-
Mark
Amyloidosis and Risk of Stroke After Transcatheter Aortic Valve Replacement : It Takes Two to Tango?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components
(
- Contribution to journal › Article
- 2022
-
Mark
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
(
- Contribution to journal › Article
-
Mark
Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries
(
- Contribution to journal › Article
-
Mark
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
(
- Contribution to journal › Article
-
Mark
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease : a literature review
(
- Contribution to journal › Scientific review
- 2021
-
Mark
On the nature of mixed neurodegenerative amyloidopathies
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
(
- Contribution to journal › Article
- 2020
-
Mark
Apolipoprotein A-I in glucose metabolism and amyloidosis
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
(
- Contribution to journal › Article
-
Mark
Ultrastructural evidence for self-replication of alzheimer-associated Aβ42 amyloid along the sides of fibrils
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(21). p.11265-11273(
- Contribution to journal › Article
- 2018
-
Mark
Effects of iron on the aggregation propensity of the N-terminal fibrillogenic polypeptide of human apolipoprotein A-I
(
- Contribution to journal › Article
-
Mark
High-efficient bacterial production of human ApoA-I amyloidogenic variants
(
- Contribution to journal › Article
- 2013
-
Mark
Molecular Mechanisms in Amyloid Disorders. Novel Treatment Options in Hereditary Cystatin C Amyloid Angiopathy.
(
- Thesis › Doctoral thesis (compilation)
- 2009
-
Mark
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
(
- Contribution to journal › Article
- 2007
-
Mark
Domain swapping as a molecular mechanism in amyloidosis
(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Checking the conformational stability of cystatin C and its L68Q variant by molecular dynamics studies: Why is the L68Q variant amyloidogenic?
(
- Contribution to journal › Article
- 2000
-
Mark
L68Q cystatin C. Expression, cellular transport and turnover of the cystatin C variant forming amyloid in patients with Hereditary Cystatin C Amyloid Angiopathy (HCCAA)
2000)(
- Thesis › Doctoral thesis (compilation)
- 1998
-
Mark
Cystatin C functions in vitro and in vivo. Studies on target enzyme inhibition by cystatin C variants and cystatin C deficient mice.
1998)(
- Thesis › Doctoral thesis (compilation)
- 1997
-
Mark
Endogenous proteins as markers of glomerular function and dysfunction
1997)(
- Thesis › Doctoral thesis (compilation)
-
Mark
NMR structural studies of human cystatin C dimers and monomers
(
- Contribution to journal › Article
- 1996
-
Mark
Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution
1996) In Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology 114(3). p.303-311(
- Contribution to journal › Article
- 1990
-
Mark
The aminoterminal portion of cerebrospinal fluid cystatin C in hereditary cystatin C amyloid angiopathy is not truncated. Direct sequence analysis from agarose gel electropherograms
(
- Contribution to journal › Article
- 1988
-
Mark
Efficient production of native, biologically active human cystatin C by Escherichia coli
(
- Contribution to journal › Article
-
Mark
Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen
(
- Contribution to journal › Article